{"transactions":[{"id":2238814,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Acctg Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-08T18:33:46.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 7, 2022, and 25% of the total number of shares of common stock subject to the option vests on June 6, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":25.19,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-035196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340652/000120919122035196/doc4.xml","form_type":"4"}},{"id":2975457,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-19T01:44:39.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":5094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested as to 25% of the units on November 16, 2020 and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service with the Issuer or any of its subsidiaries through each such vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested as to 25% of the units on November 16, 2020 and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service with the Issuer or any of its subsidiaries through each such vesting date, and have no expiration date."}],"balance_after":15282,"derivative":{"underlying":"Common Stock","underlying_shares":5094},"source":{"system":"sec-edgar","filing":"0000899243-20-031586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031586/doc4.xml","form_type":"4"}},{"id":2975456,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-19T01:44:39.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and November 16, 2020 an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and November 16, 2020 an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":5586,"derivative":{"underlying":"Common Stock","underlying_shares":399},"source":{"system":"sec-edgar","filing":"0000899243-20-031586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031586/doc4.xml","form_type":"4"}},{"id":2975455,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-11-19T01:44:39.000Z","date":"2020-11-16","kind":"tax_withholding","acquired":false,"shares":1900,"price":44.33,"value":84227.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 5,493 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":4586,"source":{"system":"sec-edgar","filing":"0000899243-20-031586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031586/doc4.xml","form_type":"4"}},{"id":2975454,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-11-19T01:44:39.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":5493,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":6486,"source":{"system":"sec-edgar","filing":"0000899243-20-031586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031586/doc4.xml","form_type":"4"}},{"id":3054516,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-18T22:58:10.000Z","date":"2020-08-16","kind":"exercise","acquired":false,"shares":398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":5985,"derivative":{"underlying":"Common Stock","underlying_shares":398},"source":{"system":"sec-edgar","filing":"0000899243-20-022785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022785/doc4.xml","form_type":"4"}},{"id":3054515,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-08-18T22:58:10.000Z","date":"2020-08-16","kind":"tax_withholding","acquired":false,"shares":138,"price":28.53,"value":3937.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 398 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":993,"source":{"system":"sec-edgar","filing":"0000899243-20-022785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022785/doc4.xml","form_type":"4"}},{"id":3054514,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-08-18T22:58:10.000Z","date":"2020-08-16","kind":"exercise","acquired":true,"shares":398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 733 shares acquired by the Reporting Person on August 14, 2020 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":1131,"source":{"system":"sec-edgar","filing":"0000899243-20-022785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022785/doc4.xml","form_type":"4"}},{"id":3120656,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-06T00:02:15.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":6383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date."}],"balance_after":6383,"derivative":{"underlying":"Common Stock","underlying_shares":6383},"source":{"system":"sec-edgar","filing":"0000899243-20-015541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015541/doc4.xml","form_type":"4"}},{"id":3120655,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-06T00:02:15.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":45931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the \"Vesting Commencement Date\"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date."}],"balance_after":45931,"derivative":{"exercise_price":28.86,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":45931},"source":{"system":"sec-edgar","filing":"0000899243-20-015541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015541/doc4.xml","form_type":"4"}},{"id":3341085,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-17T02:07:41.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":55652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":55652,"derivative":{"underlying":"Common Stock","underlying_shares":55652},"source":{"system":"sec-edgar","filing":"0000899243-19-029357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319029357/doc4.xml","form_type":"4"}},{"id":3369983,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2019-11-16T00:21:34.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":20376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units shall vest as to 25% of the units on November 16, 2020, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."}],"balance_after":20376,"derivative":{"underlying":"Common Stock","underlying_shares":20376},"source":{"system":"sec-edgar","filing":"0000899243-19-027431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319027431/doc4.xml","form_type":"4"}},{"id":3369982,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":126401,"kind":"person","name":"YAU YI CHING","position":1,"cik":"0001790097","reported_name":"YAU YI CHING","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-16T00:21:34.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":78148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable as to 25% of the shares on October 7, 2020, and as to 1/48th of the shares each month thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":78148,"derivative":{"exercise_price":26.28,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":78148},"source":{"system":"sec-edgar","filing":"0000899243-19-027431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319027431/doc4.xml","form_type":"4"}}]}